To explore the associations of the metabolic syndrome (MetS) and individual components with macular thickness and volume among rural-dwelling Chinese older adults.
Methods:
This population-based cross-sectional study included 705 participants (age ≥60 years) derived from the MIND-China study. In 2018–2019, we collected data through face-to-face interview, clinical examination, optical coherence tomography (OCT) examination, and blood test. We measured macular thickness and volume using spectral-domain OCT. MetS was defined following the International Diabetes Federation (IDF) criteria, the IDF/American Heart Association (AHA) criteria, the National Cholesterol Education Program-Adult Treatment Panel III criteria, and the Chinese Diabetes Society (CDS) criteria. Data were analyzed with multivariable general linear models.
Results:
MetS was significantly associated with thinner macula in central (multivariable-adjusted β = −5.29; 95% confidence interval: −9.31 to −1.26), parafoveal (−2.85; −5.73 to 0.04) and perifoveal regions (−4.37; −6.79 to −1.95) when using the IDF criteria, in the perifoveal regions (−3.82; −6.18 to −1.47) when using the IDF/AHA criteria, and in the central region (−5.63; −10.25 to −1.02) when using the CDS criteria, and with reduced macular volume when using the IDF (−0.16; −0.26 to −0.07) and IDF/AHA (−0.13; −0.22 to −0.04) criteria. In the parafoveal region, the IDF-defined MetS was significantly associated with thinner retina in men (β = −6.25; −10.94 to −1.56) but not in women. Abdominal obesity (−2.83; −5.41 to −0.25) and elevated fasting blood glucose (−2.65; −5.08 to −0.21) were associated with thinner macular thickness in the perifoveal region.
Conclusion:
MetS is associated with macular thinning and reduced macular volume among rural-dwelling older adults, and the associations vary by the defining criteria of MetS.
Get full access to this article
View all access options for this article.
References
1.
McNeillAM, RosamondWD, GirmanCJ, et al.The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 2005; 28(2):385–390; doi: 10.2337/diacare.28.2.385
2.
ElhadadMA, WilsonR, ZaghloolSB, et al.Metabolic syndrome and the plasma proteome: From association to causation. Cardiovasc Diabetol, 2021; 20(1):111; doi: 10.1186/s12933-021-01299-2
3.
O'NeillS, O'DriscollL. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes Rev, 2015; 16(1):1–12; doi: 10.1111/obr.12229
4.
JoyalJS, GantnerML, SmithLEH. Retinal energy demands control vascular supply of the retina in development and disease: The role of neuronal lipid and glucose metabolism. Prog Retin Eye Res, 2018; 64:131–156; doi: 10.1016/j.preteyeres.2017.11.002
5.
SnyderPJ, AlberJ, AltC, et al.Retinal imaging in Alzheimer's and neurodegenerative diseases. Alzheimers Dement, 2021; 17(1):103–111; doi: 10.1002/alz.12179
6.
JiaX, ZhongZ, BaoT, et al.Evaluation of early retinal nerve injury in type 2 diabetes patients without diabetic retinopathy. Front Endocrinol (Lausanne), 2020; 11:475672; doi: 10.3389/fendo.2020.475672
7.
De ClerckEEB, SchoutenJSAG, BerendschotTTJM, et al.Loss of temporal peripapillary retinal nerve fibers in prediabetes or type 2 diabetes without diabetic retinopathy: The Maastricht Study. Invest Ophthalmol Vis Sci, 2017; 58(2):1017–1027; doi: 10.1167/iovs.16-19638
8.
De ClerckEEB, SchoutenJ, BerendschotT, et al.Macular thinning in prediabetes or type 2 diabetes without diabetic retinopathy: The Maastricht Study. Acta Ophthalmol, 2018; 96(2):174–182; doi: 10.1111/aos.13570
9.
WongTY, DuncanBB, GoldenSH, et al.Associations between the metabolic syndrome and retinal microvascular signs: The Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci, 2004; 45(9):2949–2954; doi: 10.1167/iovs.04-0069
10.
ZhaoY, YangK, WangF, et al.Associations between metabolic syndrome and syndrome components and retinal microvascular signs in a rural Chinese population: The Handan Eye Study. Graefes Arch Clin Exp Ophthalmol, 2012; 250(12):1755–1763; doi: 10.1007/s00417-012-2109-2
11.
KeenanJD, FanAZ, KleinR. Retinopathy in nondiabetic persons with the metabolic syndrome: Findings from the Third National Health and Nutrition Examination Survey. Am J Ophthalmol, 2009; 147(5):934–944, 944.e1–e2; doi: 10.1016/j.ajo.2008.12.009
12.
PengXY, WangFH, LiangYB, et al.Retinopathy in persons without diabetes: The Handan Eye Study. Ophthalmology, 2010; 117(3):531–537, 537.e1–e2; doi: 10.1016/j.ophtha.2009.07.045
13.
NewSH, LeowSN, VasudevanSK, et al.Relationship between anthropometric and biochemical changes of metabolic syndrome with retinal nerve fiber layer and macular thickness. PLoS One, 2021; 16(2):e0246830; doi: 10.1371/journal.pone.0246830
14.
ZareiR, AnvariP, EslamiY, et al.Retinal nerve fibre layer thickness is reduced in metabolic syndrome. Diabet Med, 2017; 34(8):1061–1066; doi: 10.1111/dme.13369
15.
BaksheevaVE, TiulinaVV, TikhomirovaNK, et al.Suppression of light-induced oxidative stress in the retina by mitochondria-targeted antioxidant. Antioxidants (Basel), 2018; 8(1):3; doi: 10.3390/antiox8010003
16.
CurcioCA, AllenKA. Topography of ganglion cells in human retina. J Comp Neurol, 1990; 300(1):5–25; doi: 10.1002/cne.903000103
17.
BourneRRA, FlaxmanSR, BraithwaiteT, et al.Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: A systematic review and meta-analysis. Lancet Glob Health, 2017; 5(9):e888–e897; doi: 10.1016/S2214-109X(17)30293-0
18.
KassiE, PervanidouP, KaltsasG, et al.Metabolic syndrome: Definitions and controversies. BMC Med, 2011; 9:48; doi: 10.1186/1741-7015-9-48
19.
WangY, HanX, ZhangX, et al.Health status and risk profiles for brain aging of rural-dwelling older adults: Data from the interdisciplinary baseline assessments in MIND-China. Alzheimers Dement (N Y), 2022; 8(1):e12254; doi: 10.1002/trc2.12254
20.
KivipeltoM, MangialascheF, SnyderHM, et al.World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimers Dement, 2020; 16(7):1078–1094; doi: 10.1002/alz.12123
21.
RossR, NeelandIJ, YamashitaS, et al.Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol, 2020; 16(3):177–189; doi: 10.1038/s41574-019-0310-7
22.
WangS, ZhangQ, HouT, et al.Differential associations of 6 adiposity indices with dementia in older adults: The MIND-China Study. J Am Med Dir Assoc, 2023; 24(9):1412–1419.e4; doi: 10.1016/j.jamda.2023.06.029
23.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285(19):2486–2497; doi: 10.1001/jama.285.19.2486
24.
AlbertiKG, ZimmetP, ShawJ. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 2006; 23(5):469–480; doi: 10.1111/j.1464-5491.2006.01858.x
25.
AlbertiKG, EckelRH, GrundySM, et al.Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120(16):1640–1645; doi: 10.1161/circulationaha.109.192644
26.
Metabolic syndrome research collaboration group from Chinese Diabetes Society. Suggestions on metabolic syndrome from Chinese Diabetes Society. Chin J Diabetes, 2004; 12(3):151–161.
27.
Early Treatment Diabetic Retinopathy Study Research Group. Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House Classification. Ophthalmology, 1991; 98(5):786–806; doi: 10.1016/s0161-6420(13)38012-9
28.
KaracaC, KaracaZ. Beyond hyperglycemia, evidence for retinal neurodegeneration in metabolic syndrome. Invest Ophthalmol Vis Sci, 2018; 59(3):1360–1367; doi: 10.1167/iovs.17-23376
29.
PolatE, CelikE, TogacM, et al.Retinal neurodegeneration in metabolic syndrome: A spectral optical coherence tomography study. Int J Ophthalmol, 2023; 16(2):224–232; doi: 10.1824/0/ijo.2023.02.08
30.
KolbH, NelsonRF, AhneltPK, et al.The Architecture of the Human Fovea. In: Webvision: The Organization of the Retina and Visual System. (KolbH, FernandezE, NelsonR. eds.) University of Utah Health Sciences Center: Salt Lake City (UT); 1995.
31.
Monserrat-MesquidaM, Quetglas-LlabrésM, CapóX, et al.Metabolic syndrome is associated with oxidative stress and proinflammatory state. Antioxidants (Basel), 2020; 9(3):236; doi: 10.3390/antiox9030236
32.
JanusA, Szahidewicz-KrupskaE, MazurG, et al.Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders. Mediators Inflamm, 2016; 2016:3634948; doi: 10.1155/2016/3634948
33.
GrandlG, WolfrumC. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin Immunopathol, 2018; 40(2):215–224; doi: 10.1007/s00281-017-0666-5
34.
PazMC, BarcelonaPF, SubiradaPV, et al.Metabolic syndrome triggered by fructose diet impairs neuronal function and vascular integrity in ApoE-KO mouse retinas: Implications of autophagy deficient activation. Front Cell Dev Biol, 2020; 8:573987; doi: 10.3389/fcell.2020.573987
35.
LaclaustraM, CorellaD, OrdovasJM. Metabolic syndrome pathophysiology: The role of adipose tissue. Nutr Metab Cardiovasc Dis, 2007; 17(2):125–139; doi: 10.1016/j.numecd.2006.10.005
36.
BenarrochEE. Insulin-like growth factors in the brain and their potential clinical implications. Neurology, 2012; 79(21):2148–2153; doi: 10.1212/WNL.0b013e3182752eef
37.
MyersCE, KleinBEK, MeuerSM, et al.Retinal thickness measured by spectral-domain optical coherence tomography in eyes without retinal abnormalities: The Beaver Dam Eye Study. Am J Ophthalmol, 2015; 159(3):445–456.e1; doi: 10.1016/j.ajo.2014.11.025
38.
PatelPJ, FosterPJ, GrossiCM, et al.Spectral-domain optical coherence tomography imaging in 67,321 adults: Associations with Macular Thickness in the UK Biobank Study. Ophthalmology, 2016; 123(4):829–840; doi: 10.1016/j.ophtha.2015.11.009
39.
GuptaP, SidharthaE, ThamYC, et al.Determinants of macular thickness using spectral domain optical coherence tomography in healthy eyes: The Singapore Chinese Eye study. Invest Ophthalmol Vis Sci, 2013; 54(13):7968–7976; doi: 10.1167/iovs.13-12436
40.
von HannoT, LadeAC, MathiesenEB, et al.Macular thickness in healthy eyes of adults (N = 4508) and relation to sex, age and refraction: The Tromsø Eye Study (2007–2008). Acta Ophthalmol, 2017; 95(3):262–269; doi: 10.1111/aos.13337
41.
OguetaSB, SchwartzSD, YamashitaCK, et al.Estrogen receptor in the human eye: Influence of gender and age on gene expression. Invest Ophthalmol Vis Sci, 1999; 40(9):1906–1911.
42.
GuptaPD, JoharK, NagpalK, et al.Sex hormone receptors in the human eye. Surv Ophthalmol, 2005; 50(3):274–284; doi: 10.1016/j.survophthal.2005.02.005.
43.
KanderMC, CuiY, LiuZ. Gender difference in oxidative stress: A new look at the mechanisms for cardiovascular diseases. J Cell Mol Med, 2017; 21(5):1024–1032; doi: 10.1111/jcmm.13038
44.
FaulknerJL, Belin de ChantemeleEJ. Sex hormones, aging and cardiometabolic syndrome. Biol Sex Differ, 2019; 10(1):30; doi: 10.1186/s13293-019-0246-6
45.
MillerAA, De SilvaTM, JackmanKA, et al.Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol, 2007; 34(10):1037–1043; doi: 10.1111/j.1440-1681.2007.04732.x
46.
OussaadaSM, van GalenKA, CooimanMI, et al.The pathogenesis of obesity. Metabolism, 2019; 92:26–36; doi: 10.1016/j.metabol.2018.12.012
47.
ShibaC, ShibaT, TakahashiM, et al.Relationships among serum lipoprotein lipase mass, visceral fat, and retinal nerve fiber layer thickness. Graefes Arch Clin Exp Ophthalmol, 2015; 253(11):1883–1888; doi: 10.1007/s00417-014-2898-6
48.
BlochE, Yonova-DoingE, Jones-OdehE, et al.Genetic and environmental factors associated with the ganglion cell complex in a healthy aging British Cohort. JAMA Ophthalmol, 2017; 135(1):31–38; doi: 10.1001/jamaophthalmol.2016.4486
49.
KohVT, ThamYC, CheungCY, et al.Determinants of ganglion cell-inner plexiform layer thickness measured by high-definition optical coherence tomography. Invest Ophthalmol Vis Sci, 2012; 53(9):5853–5859; doi: 10.1167/iovs.12-10414.
50.
ThamYC, CheeML, DaiW, et al.Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study. Ophthalmology, 2020; 127(8):1064–1076; doi: 10.1016/j.ophtha.2020.01.055
51.
KhawajaAP, ChuaS, HysiPG, et al.Comparison of associations with different macular inner retinal thickness parameters in a Large Cohort: The UK Biobank. Ophthalmology, 2020; 127(1):62–71; doi: 10.1016/j.ophtha.2019.08.015
52.
LiangY, YanZ, HaoY, et al.Metabolic syndrome in patients with first-ever ischemic stroke: Prevalence and association with coronary heart disease. Sci Rep, 2022; 12(1):13042; doi: 10.1038/s41598-022-17369-8
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
